{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:32:58Z","timestamp":1791484378382,"version":"4.3.4"},"reference-count":150,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008771","name":"Tourette Association of America","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008771","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.biopsych.2018.02.1172","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T21:07:36Z","timestamp":1520543256000},"page":"332-344","source":"Crossref","is-referenced-by-count":118,"title":["Dopaminergic Disturbances in Tourette Syndrome: An Integrative Account"],"prefix":"10.1016","volume":"84","author":[{"given":"Tiago V.","family":"Maia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco A.","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2018.02.1172_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.410120408","article-title":"Dopaminergic dysfunction in Tourette syndrome","volume":"12","author":"Singer","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archpsyc.1974.01760180095012","article-title":"Presynaptic catecholamine antagonists as treatment for Tourette syndrome: Effects of alpha methyl para tyrosine and tetrabenazine","volume":"31","author":"Sweet","year":"1974","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neubiorev.2012.10.004","article-title":"Neuromodulation in Tourette syndrome: Dopamine and beyond","volume":"37","author":"Buse","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib4","series-title":"Tourette Syndrome","first-page":"276","article-title":"The neurochemistry of Tourette syndrome","author":"Singer","year":"2013"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biopsych.2017.05.025","article-title":"The roles of phasic and tonic dopamine in tic learning and expression","volume":"82","author":"Maia","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.conb.2017.08.009","article-title":"Premonitory urges and tics in Tourette syndrome: Computational mechanisms and neural correlates","volume":"46","author":"Concei\u00e7\u00e3o","year":"2017","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib7","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1523\/JNEUROSCI.09-06-02051.1989","article-title":"Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in\u00a0vivo microdialysis","volume":"9","author":"Kuczenski","year":"1989","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(86)90002-6","article-title":"Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: A brain dialysis study","volume":"132","author":"Zetterstr\u00f6m","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","article-title":"Controlled stimulant treatment of ADHD and comorbid Tourette\u2019s syndrome: Effects of stimulant and dose","volume":"36","author":"Castellanos","year":"1997","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00404607","article-title":"Stereotyped activities produced by amphetamine in several animal species and man","volume":"11","author":"Randrup","year":"1967","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.neubiorev.2013.03.014","article-title":"Theoretical and practical considerations behind the use of laboratory animals for the study of Tourette syndrome","volume":"37","author":"Macr\u00ec","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(73)90028-9","article-title":"Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol","volume":"22","author":"Asper","year":"1973","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-8993(99)01395-5","article-title":"Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs","volume":"830","author":"Cho","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0361-9230(87)90042-6","article-title":"Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in\u00a0vivo: Depolarization block as a possible mechanism of action","volume":"18","author":"Lane","year":"1987","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ana.410300408","article-title":"Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette\u2019s syndrome","volume":"30","author":"Singer","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2007.01.069","article-title":"Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis","volume":"255","author":"Yoon","year":"2007","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2003.12.006","article-title":"Increased prefrontal D2 protein in Tourette syndrome: A postmortem analysis of frontal cortex and striatum","volume":"219","author":"Minzer","year":"2004","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","article-title":"Elevated intrasynaptic dopamine release in Tourette\u2019s syndrome measured by PET","volume":"159","author":"Singer","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaac.2015.06.011","article-title":"Meta-analysis: Risk of tics associated with psychostimulant use in randomized, placebo-controlled trials","volume":"54","author":"Cohen","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.1982.03320370043028","article-title":"Stimulant medications precipitate Tourette\u2019s syndrome","volume":"247","author":"Lowe","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: Pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/070674371205700302","article-title":"Canadian guidelines for the evidence-based treatment of tic disorders: Pharmacotherapy","volume":"57","author":"Pringsheim","year":"2012","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00004583-199301000-00030","article-title":"Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette\u2019s syndrome","volume":"32","author":"Spencer","year":"1993","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib25","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","article-title":"Systematic review: Pharmacological treatment of tic disorders\u2014Efficacy of antipsychotic and alpha-2 adrenergic agonist agents","volume":"37","author":"Weisman","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib26","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1523\/JNEUROSCI.1894-10.2010","article-title":"Influence of phasic and tonic dopamine release on receptor activation","volume":"30","author":"Dreyer","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib27","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1017\/S1461145711000010","article-title":"Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment","volume":"14","author":"Amato","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib28","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1073\/pnas.0707646105","article-title":"Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter","volume":"105","author":"Salahpour","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib29","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nn1103","article-title":"Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission","volume":"6","author":"Floresco","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib30","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1471-4159.2003.02109.x","article-title":"Real-time decoding of dopamine concentration changes in the caudate\u2013putamen during tonic and phasic firing","volume":"87","author":"Venton","year":"2003","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1741-7007-3-4","article-title":"Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: A model of obsessive compulsive disorder and Tourette\u2019s","volume":"3","author":"Berridge","year":"2005","journal-title":"BMC Biol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tips.2011.05.001","article-title":"Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia","volume":"32","author":"Lodge","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004583-199901000-00024","article-title":"High presynaptic dopaminergic activity in children with Tourette\u2019s disorder","volume":"38","author":"Ernst","year":"1999","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12149-010-0389-3","article-title":"Evaluation of Tourette\u2019s syndrome by 99mTc-TRODAT-1 SPECT\/CT imaging","volume":"24","author":"Liu","year":"2010","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib35","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1176\/ajp.152.9.1359","article-title":"[123I]\u03b2-CIT SPECT imaging of striatal dopamine transporter binding in Tourette\u2019s disorder","volume":"152","author":"Malison","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib36","first-page":"514","article-title":"Dopamine transporter binding in Gilles de la Tourette syndrome","volume":"247","author":"M\u00fcller-Vahl","year":"2000","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.0001-690X.2004.00214.x","article-title":"Dopamine transporter binding in Gilles de la Tourette syndrome: A [123I]FP-CIT\/SPECT study","volume":"109","author":"Serra-Mestres","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pscychresns.2003.06.001","article-title":"Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette\u2019s disorder","volume":"130","author":"Cheon","year":"2004","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib39","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/WNL.0b013e3181a187dd","article-title":"Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome","volume":"72","author":"Albin","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib40","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","article-title":"Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: Clues from an in\u00a0vivo neurochemistry study with PET","volume":"33","author":"Wong","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.mnm.0000239485.53780.16","article-title":"Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette\u2019s adults","volume":"27","author":"Yeh","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pscychresns.2007.01.003","article-title":"Phasic dysfunction of dopamine transmission in Tourette\u2019s syndrome evaluated with 99mTc TRODAT-1 imaging","volume":"156","author":"Yeh","year":"2007","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib43","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.51.4.1069","article-title":"Tourette\u2019s syndrome: [I-123]\u03b2-CIT SPECT correlates of vocal tic severity","volume":"51","author":"Heinz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pscychresns.2007.04.006","article-title":"[99mTc]TRODAT-1\/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome","volume":"162","author":"Hwang","year":"2008","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0924-977X(00)00134-6","article-title":"No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette\u2019s disorder patients: A [123I]-\u03b2-CIT SPECT-study","volume":"11","author":"Stamenkovic","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib46","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1176\/appi.ajp.158.9.1492","article-title":"Striatal dopamine transporters and cognitive functioning in healthy men and women","volume":"158","author":"Mozley","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jocn.2011.05.013","article-title":"Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults","volume":"19","author":"Wong","year":"2012","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.WNL.0000076181.39162.FC","article-title":"Increased ventral striatal monoaminergic innervation in Tourette syndrome","volume":"61","author":"Albin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.53.2.371","article-title":"Striatal presynaptic monoaminergic vesicles are not increased in Tourette\u2019s syndrome","volume":"53","author":"Meyer","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib50","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1007\/s00429-015-1125-5","article-title":"Serotonin hyperinnervation of the striatum with high synaptic incidence in Parkinsonian monkeys","volume":"221","author":"Gagnon","year":"2016","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib51","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","article-title":"Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder","volume":"23","author":"Denys","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.21809","article-title":"Extrastriatal dopaminergic dysfunction in Tourette syndrome","volume":"67","author":"Steeves","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.12688\/f1000research.5672.1","article-title":"Levodopa effects on [11C]raclopride binding in the resting human brain","volume":"4","author":"Black","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib54","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jnnp.57.6.688","article-title":"PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette\u2019s syndrome","volume":"57","author":"Turjanski","year":"1994","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib55","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/hbm.22793","article-title":"Similar striatal D2\/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [11C]-(+)-PHNO and [11C]raclopride positron emission tomography imaging study","volume":"36","author":"Abi-Jaoude","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2000.101003165.x","article-title":"Dopamine D2 receptor imaging in Gilles de la Tourette syndrome","volume":"101","author":"M\u00fcller-Vahl","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0925-4927(94)90014-0","article-title":"Dopamine receptor availability in Tourette\u2019s syndrome","volume":"55","author":"George","year":"1994","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib58","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1212\/01.wnl.0000242733.18534.2c","article-title":"Altered mesolimbocortical and thalamic dopamine in Tourette syndrome","volume":"67","author":"Gilbert","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib59","series-title":"Imaging of the Human Brain in Health and Disease","first-page":"289","article-title":"Dopamine receptors and dopamine release","author":"Kessler","year":"2014"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/syn.20360","article-title":"Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy","volume":"61","author":"Goggi","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","article-title":"Imaging synaptic neurotransmission with in\u00a0vivo binding competition techniques: A critical review","volume":"20","author":"Laruelle","year":"2000","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib62","first-page":"1243","article-title":"D2-like dopamine receptor density in Tourette syndrome measured by PET","volume":"38","author":"Wong","year":"1997","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib63","series-title":"The Dopamine Receptors, 2nd ed","first-page":"431","article-title":"Dopamine receptors and the treatment of schizophrenia","author":"Ginovart","year":"2010"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib64","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","article-title":"Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding","volume":"273","author":"Wolf","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib65","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jlcr.3558","article-title":"Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies","volume":"61","author":"Mach","year":"2018","journal-title":"J\u00a0Labelled Comp Radiopharm"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib66","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1098-2396(20001201)38:3<338::AID-SYN13>3.0.CO;2-N","article-title":"SPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors","volume":"38","author":"Videbaek","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib67","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","article-title":"Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy","volume":"54","author":"Tziortzi","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib68","unstructured":"Baker A (2016): Simplicity. The Stanford Encyclopedia of Philosophy (Winter 2016 Edition), Edward N. Zalta (ed.). Available at: https:\/\/plato.stanford.edu\/archives\/win2016\/entries\/simplicity\/. Accessed April 3, 2018."},{"key":"10.1016\/j.biopsych.2018.02.1172_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0306-4522(90)90221-O","article-title":"The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum","volume":"39","author":"Delfs","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib70","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/BF01897450","article-title":"Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats","volume":"22","author":"Ernst","year":"1966","journal-title":"Experientia"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib71","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-8993(89)91368-1","article-title":"Enhanced behavioral stereotypies elicited by intrastriatal injection of D1 and D2 dopamine agonists in intact rats","volume":"504","author":"Bordi","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib72","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.2953072","article-title":"D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects","volume":"236","author":"Walters","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(74)90023-5","article-title":"Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra","volume":"29","author":"Price","year":"1974","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","article-title":"Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum","volume":"94","author":"Kelly","year":"1975","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ncl.2014.09.008","article-title":"Tics and Tourette syndrome","volume":"33","author":"Ganos","year":"2015","journal-title":"Neurol Clin"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib76","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s40265-014-0254-0","article-title":"The role of atypical antipsychotics for treatment of Tourette\u2019s syndrome: An overview","volume":"74","author":"Budman","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib77","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/JCP.0b013e3182983ffa","article-title":"Estimating dopamine D\u2082 receptor occupancy for doses of 8 antipsychotics: A meta-analysis","volume":"33","author":"Lako","year":"2013","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib78","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF00166898","article-title":"Chronic clozapine versus chronic haloperidol treatment: Differential effects on electrically evoked dopamine efflux in the rat caudate putamen, but not in the nucleus accumbens","volume":"354","author":"Feasey-Truger","year":"1996","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib79","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/01.WNL.0000044058.64647.7E","article-title":"Tic reduction with pergolide in a randomized controlled trial in children","volume":"60","author":"Gilbert","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib80","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","article-title":"Tourette\u2019s syndrome improvement with pergolide in a randomized, double-blind, crossover trial","volume":"54","author":"Gilbert","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib81","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mds.870120320","article-title":"Dopamine agonist treatment of Tourette disorder in children: Results of an open-label trial of pergolide","volume":"12","author":"Lipinski","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00004714-198212000-00002","article-title":"Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: Implications for prevention or treatment of tardive dyskinesia","volume":"2","author":"Fuller","year":"1982","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(87)90619-6","article-title":"Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: A neurophysiological study","volume":"400","author":"Carlson","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib84","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1476-5381.1985.tb17379.x","article-title":"Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis","volume":"84","author":"Brown","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01271541","article-title":"Effect of pergolide on endogenous and exogenous L-DOPA metabolism in the rat striatum: A microdialysis study","volume":"101","author":"Dethy","year":"1995","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib86","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0028-3908(84)90190-4","article-title":"Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain","volume":"23","author":"Jiang","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib87","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.24919","article-title":"A\u00a0multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette\u2019s syndrome","volume":"27","author":"Kurlan","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib88","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/npp.2008.114","article-title":"Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain","volume":"34","author":"Chernoloz","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib89","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1503\/jpn.110038","article-title":"Long-term administration of the dopamine D3\/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain","volume":"37","author":"Chernoloz","year":"2012","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib90","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nbd.2014.12.007","article-title":"Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake","volume":"74","author":"Castro-Hern\u00e1ndez","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7007-2-22","article-title":"Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson\u2019s disease, and downregulates the dopamine transporter via the D3 receptor","volume":"2","author":"Joyce","year":"2004","journal-title":"BMC Biol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib92","first-page":"309","article-title":"Deterioration in parkinsonism with low-dose pergolide","volume":"246","author":"Kellett","year":"1999","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mds.23396","article-title":"Twice-daily, low-dose pramipexole in early Parkinson\u2019s disease: A randomized, placebo-controlled trial","volume":"26","author":"Kieburtz","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib94","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1212\/01.WNL.0000123111.00324.BF","article-title":"Ropinirole in Gilles de la Tourette syndrome","volume":"62","author":"Anca","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib95","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mds.870090306","article-title":"Talipexole and adult Gilles de la Tourette\u2019s syndrome: Double-blind, placebo-controlled clinical trial","volume":"9","author":"Goetz","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib96","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2011.05.050","article-title":"Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors","volume":"666","author":"Tadori","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib97","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D2-like receptor and \u03b11\/\u03b12-adrenoceptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib98","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib99","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1021\/acschemneuro.7b00087","article-title":"Classics in chemical neuroscience: Aripiprazole","volume":"8","author":"Casey","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","article-title":"7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity","volume":"274","author":"Kikuchi","year":"1995","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib101","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2045125316672136","article-title":"Brexpiprazole and cariprazine: Distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole","volume":"7","author":"Frankel","year":"2017","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib102","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00173016","article-title":"Presynaptic \u03b12A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices","volume":"350","author":"Trendelenburg","year":"1994","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib103","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(97)01375-7","article-title":"\u03b12-Adrenergic control of dopamine overflow and metabolism in mouse striatum","volume":"339","author":"Yavich","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneumeth.2004.04.040","article-title":"Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: Release from adrenergic terminals and modulation by \u03b12-autoreceptors","volume":"140","author":"Gobert","year":"2004","journal-title":"J\u00a0Neurosci Methods"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1471-4159.2004.02691.x","article-title":"In\u00a0vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens","volume":"91","author":"Ihalainen","year":"2004","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/026988110001400202","article-title":"Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: Relevance to the actions of antidepressant agents","volume":"14","author":"Millan","year":"2000","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib107","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7424.1","article-title":"Recent advances in understanding and managing Tourette syndrome","volume":"5","author":"Thenganatt","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/WNF.0000000000000017","article-title":"A\u00a0D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome","volume":"37","author":"Gilbert","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib109","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-3565(25)13263-1","article-title":"Pharmacological profile of SCH39166: A dopamine D1 selective benzonaphthazepine with potential antipsychotic activity","volume":"247","author":"Chipkin","year":"1988","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.102.1.14","article-title":"Course of tic severity in Tourette syndrome: The first two decades","volume":"102","author":"Leckman","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib111","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1471-4159.2003.02017.x","article-title":"Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum","volume":"87","author":"Haycock","year":"2003","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1471-4159.1976.tb04437.x","article-title":"Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson\u2019s disease and Huntington\u2019s chorea","volume":"26","author":"McGeer","year":"1976","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib113","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0893-133X(99)00062-7","article-title":"Developmental regulation of the dopamine D1 receptor in human caudate and putamen","volume":"21","author":"Montague","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib114","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/syn.890010503","article-title":"Human brain dopamine receptors in children and aging adults","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0006-8993(99)01933-2","article-title":"Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia","volume":"843","author":"Meng","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib116","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1460-9568.2009.06648.x","article-title":"Age matters","volume":"29","author":"McCutcheon","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib117","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neubiorev.2009.12.007","article-title":"Neurobehavioral evidence for changes in dopamine system activity during adolescence","volume":"34","author":"Wahlstrom","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib118","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tins.2017.05.004","article-title":"The role of interneurons in autism and Tourette syndrome","volume":"40","author":"Rapanelli","year":"2017","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib119","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/B978-0-12-411546-0.00004-4","article-title":"Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome","volume":"112","author":"Udvardi","year":"2013","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1517\/21678707.2016.1128819","article-title":"Histaminergic modulation in Tourette syndrome","volume":"4","author":"Cox","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib121","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nn.2723","article-title":"From reinforcement learning models to psychiatric and neurological disorders","volume":"14","author":"Maia","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib122","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopsych.2016.05.021","article-title":"An integrative perspective on the role of dopamine in schizophrenia","volume":"81","author":"Maia","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib123","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib124","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/mds.23778","article-title":"A\u00a0within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson\u2019s disease","volume":"26","author":"Gallagher","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib125","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1176\/appi.ajp.2011.09111692","article-title":"The neural circuits that generate tics in Tourette\u2019s syndrome","volume":"168","author":"Wang","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib126","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/syn.20623","article-title":"Dopaminergic synapses in the caudate of subjects with schizophrenia: Relationship to treatment response","volume":"63","author":"Roberts","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib127","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.20765","article-title":"Increased midbrain gray matter in Tourette\u2019s syndrome","volume":"59","author":"Garraux","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib128","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mp.2016.194","article-title":"Brain structure in pediatric Tourette syndrome","volume":"22","author":"Greene","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib129","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/mds.25975","article-title":"Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts","volume":"29","author":"Kraemmer","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum","volume":"23","author":"Martinez","year":"2003","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib131","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","article-title":"How addictive drugs disrupt presynaptic dopamine neurotransmission","volume":"69","author":"Sulzer","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib132","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib133","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1755-5949.2008.00058.x","article-title":"Enhancing aromatic L-amino acid decarboxylase activity: Implications for L-DOPA treatment in Parkinson\u2019s disease","volume":"14","author":"Hadjiconstantinou","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib134","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/syn.1071","article-title":"Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in\u00a0vivo","volume":"41","author":"Danielsen","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.baga.2016.02.001","article-title":"Striatal dopamine neurotransmission: Regulation of release and uptake","volume":"6","author":"Sulzer","year":"2016","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib136","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.2009.05148.x","article-title":"Regulation of the dopamine transporter","volume":"1187","author":"Schmitt","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014053","article-title":"Dopamine transporter binding is unaffected by L-DOPA administration in\u00a0normal and MPTP-treated monkeys","volume":"5","author":"Fernagut","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib138","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1007\/s00259-010-1581-3","article-title":"Levodopa and pramipexole effects on presynaptic dopamine PET markers and estimated dopamine release","volume":"37","author":"Sossi","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib139","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/schbul\/sbr180","article-title":"Striatal presynaptic dopamine in schizophrenia, Part II: Meta-analysis of [18F\/11C]-DOPA PET studies","volume":"39","author":"Fusar-Poli","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/schbul\/sbr111","article-title":"Striatal presynaptic dopamine in schizophrenia, Part I: Meta-analysis of dopamine active transporter (DAT) density","volume":"39","author":"Fusar-Poli","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib141","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/syn.20653","article-title":"Visualizing vesicular dopamine dynamics in Parkinson\u2019s disease","volume":"63","author":"de la Fuente-Fern\u00e1ndez","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib142","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2016.06.037","article-title":"\u03b12A Adrenergic receptors highly expressed in mesoprefrontal dopamine neurons","volume":"332","author":"Castelli","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib143","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1523\/JNEUROSCI.17-07-02519.1997","article-title":"Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in\u00a0vivo","volume":"17","author":"Tepper","year":"1997","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib144","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2008.12.002","article-title":"Getting specialized: Presynaptic and postsynaptic dopamine D2 receptors","volume":"9","author":"De Mei","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib145","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/138161210790361461","article-title":"Third generation antipsychotic drugs: Partial agonism or receptor functional selectivity?","volume":"16","author":"Mailman","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib146","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1460-9568.2008.06423.x","article-title":"Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation","volume":"28","author":"Collo","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib147","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.0837-06.2006","article-title":"Dopamine D3 receptor agonist delivery to a model of Parkinson\u2019s disease restores the nigrostriatal pathway and improves locomotor behavior","volume":"26","author":"Van Kampen","year":"2006","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib148","doi-asserted-by":"crossref","first-page":"35842","DOI":"10.1074\/jbc.M611758200","article-title":"Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors","volume":"282","author":"Zapata","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib149","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/0192623310378027","article-title":"Drug-induced valvulopathy: An update","volume":"38","author":"Elangbam","year":"2010","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.biopsych.2018.02.1172_bib150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archpsyc.1979.01780090065007","article-title":"Effects of dopamine agonists and antagonists in Tourette\u2019s disease","volume":"36","author":"Feinberg","year":"1979","journal-title":"Arch Gen Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322318313003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322318313003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:12:43Z","timestamp":1751458363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322318313003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006322318313003"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2018.02.1172","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}